Cimzia 2X200 MG/ML syringe kits
Ended Awarded
- Contract number
- SPE2DB25FQJNU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,018
Award facts
- Contract value 100% obligated
- $41,018.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $41,018.08 to AmerisourceBergen Drug Corp for the supply of CIMZIA 2x200 mg/mL syringe kits. The contract, awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, utilizes firm fixed-price pricing and represents a non-set-aside procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle.
CIMZIA, a TNF inhibitor used to treat inflammatory conditions including rheumatoid arthritis and Crohn's disease, is a specialty pharmaceutical product aligned with AmerisourceBergen's role as a critical supplier of brand-name and generic medications, vaccines, and specialized medical supplies to military and veteran healthcare systems. The firm's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its established capability to fulfill military medical procurement requirements through competitive procurement processes. This delivery order supports the Defense Health Agency and broader DoD healthcare operations by ensuring the availability of essential therapeutic medications for military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FQJNU?
SPE2DB25FQJNU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FQJNU worth?
The government has obligated $41,018 on SPE2DB25FQJNU.
Is contract SPE2DB25FQJNU an order under another contract?
Yes. SPE2DB25FQJNU is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQJNU competed?
The extent of competition for SPE2DB25FQJNU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award